Abstract
The presence of metastatic deseases in lung cancer patients is common in everyday clinical practice.
The aim of this study is to establish frequences of bone metastases in our patients (pts). and their association with other metastases (as brain, liver etc.) and to investigate their survival and treatment effects.
Methods: The data were collected from the Hospital Registry. The investigation was carried out in non operated patients. It included 1197 newly discovered lung cancer patients., 71 (5,93%) patients had bone metastases. In the moment of the dates analysis, 62 (87,3%) were dead, and the mean survival was 2.5 month (survival range 0.1-13month). Solitary bone matastases have 25 (35,2%) patients., and multiple bone metastases have 46 (64,8%) patients, while bone and other metastases were found in 37 (52,1%) patients. Only 14 (19,7%) patients were treated with bifosfonats therapy, and their mean survival was 2 months.
Conclusion: Lung cancer patients with bone metastases, usually associated with other metastases, achieved a wary poor surviival. Neither the paliativ irradiation of solitary metastases nor bifosfonats therapy improved the survival of lung cancer patients.
- © 2011 ERS